On December 8, 2022, closed the transaction. Starting December 9, 2022, the amount equivalent to 90% of the closing price rounded up to the nearest yen will be If the exercise price exceeds or falls below the immediately preceding effective exercise price by 1 yen or more, the exercise price will be revised to the revised price on or after the revision date. However, if the price after such revision falls below ¥457, the minimum exercise price shall be the revised exercise price.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
391 JPY | -1.76% | -0.76% | -25.10% |
1st Jan change | Capi. | |
---|---|---|
-25.10% | 45.69M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- 4572 Stock
- News Carna Biosciences, Inc.
- Carna Biosciences, Inc. announced that it has received ¥11.209315 million in funding from Cantor Fitzgerald & Co.